These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 360062)
1. Insulin binding and insulin sensitivity in isolated growth hormone deficiency. Soman V; Tamborlane W; DeFronzo R; Genel M; Felig P N Engl J Med; 1978 Nov; 299(19):1025-30. PubMed ID: 360062 [TBL] [Abstract][Full Text] [Related]
2. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. DeFronzo R; Deibert D; Hendler R; Felig P; Soman V J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552 [TBL] [Abstract][Full Text] [Related]
3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
4. Increased insulin sensitivity and insulin binding to monocytes after physical training. Soman VR; Koivisto VA; Deibert D; Felig P; DeFronzo RA N Engl J Med; 1979 Nov; 301(22):1200-4. PubMed ID: 503113 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. Campbell PJ; Bolli GB; Cryer PE; Gerich JE N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524 [TBL] [Abstract][Full Text] [Related]
6. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416 [TBL] [Abstract][Full Text] [Related]
7. The relation between glucose tolerance and insulin binding to circulating monocytes in obese children. Kida K; Watanabe N; Fujisawa Y; Goto Y; Matsuda H Pediatrics; 1982 Oct; 70(4):633-7. PubMed ID: 6750546 [TBL] [Abstract][Full Text] [Related]
8. Effects of human growth hormone on erythrocyte insulin binding in growth hormone deficient children. Nagashima K; Suzuki S; Uchida S; Kuroume T Horm Metab Res; 1984 Aug; 16(8):402-5. PubMed ID: 6381273 [TBL] [Abstract][Full Text] [Related]
9. Increase in specific binding of insulin-like growth factor (IGF) II to type 1 IGF receptors on erythrocytes of hypopituitary children receiving growth hormone therapy. Costigan CD; Polychronakos C; Guyda HJ; Posner BI Clin Invest Med; 1988 Feb; 11(1):47-51. PubMed ID: 2966692 [TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes. Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067 [TBL] [Abstract][Full Text] [Related]
11. Changes in glucose, insulin, and growth hormone levels associated with bedrest. Vernikos-Danellis J; Leach CS; Winget CM; Goodwin AL; Rambaut PC Aviat Space Environ Med; 1976 Jun; 47(6):583-7. PubMed ID: 938392 [TBL] [Abstract][Full Text] [Related]
12. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. Bolli GB; Dimitriadis GD; Pehling GB; Baker BA; Haymond MW; Cryer PE; Gerich JE N Engl J Med; 1984 Jun; 310(26):1706-11. PubMed ID: 6374455 [TBL] [Abstract][Full Text] [Related]
14. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342 [TBL] [Abstract][Full Text] [Related]
15. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA; Cryer PE; Gerich JE J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [TBL] [Abstract][Full Text] [Related]
16. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186 [TBL] [Abstract][Full Text] [Related]
18. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235 [TBL] [Abstract][Full Text] [Related]
19. Increased insulin binding to erythrocytes in anorexia nervosa: restoration to normal with refeeding. Wachslicht-Rodbard H; Gross HA; Rodbard D; Ebert MH; Roth J N Engl J Med; 1979 Apr; 300(16):882-7. PubMed ID: 423938 [TBL] [Abstract][Full Text] [Related]
20. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus. Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]